Utama › Kanser Payudara › Texas › League City
Kajian klinikal Kanser Payudara di League City, TX
12 kajian untuk Kanser Payudara sedang mencari peserta di lokasi dalam dan sekitar League City (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors
Mengambil pesertaFasa 1
- NEXT Houston, Galveston · 23 mi jauh
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Mengambil pesertaFasa 3
- Tranquility Research, Webster · 3 mi jauh
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
Mengambil pesertaFasa 3
- Tranquil Clinical Research, Webster · 3 mi jauh
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Mengambil pesertaFasa 3
- UT MD Anderson - League City, League City
- Houston Methodist Saint John Hospital, Nassau Bay · 3 mi jauh
A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain Metastases
Mengambil pesertaFasa 2
- Tranquil Clinical Research, Webster · 3 mi jauh
A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors
Mengambil pesertaFasa 1
- The University of Texas, MD Anderson Cancer Center - League City, League City
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
Mengambil pesertaFasa 3
- MD Anderson League City, League City
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Mengambil pesertaFasa 3
- MD Anderson League City, League City
- Houston Methodist Saint John Hospital, Nassau Bay · 3 mi jauh
- University of Texas Medical Branch, Galveston · 23 mi jauh
Biospecimen and Medical Data Collection and Tumor Biopsy in Creating Research Tissue Registry in Patients With Inflammatory or Invasive Breast Cancer
Mengambil pesertaKajian pemerhatian
- MD Anderson League City, Nassau Bay · 3 mi jauh
Feasibility Study for the SIRA-1000, SIRA® RFA Electrosurgical Device as an Adjunct to Breast Conserving Surgery
Mengambil peserta
- University of Texas Medical Branch at Galveston, TX, Galveston · 23 mi jauh
THRIVE Well Cancer FDTN/Exercise_Creatine Supplementation
Mengambil pesertaSukarelawan sihat dialu-alukan
- The University of Texas Medical Branch, Galveston, Galveston · 23 mi jauh
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
Mengambil pesertaKajian pemerhatian
- University of Texas Medical Branch, League City
- Texas Oncology - Webster, Webster · 3 mi jauh
Kajian Kanser Payudara di bandar lain
- New York City, NY136 kajian
- Houston, TX126 kajian
- Boston, MA112 kajian
- Nashville, TN81 kajian
- Los Angeles, CA73 kajian
- Edison, NJ68 kajian
- St. Louis, MO64 kajian
- Queens, NY64 kajian
- Durham, NC64 kajian
- Chicago, IL59 kajian
- Philadelphia, PA56 kajian
- Dallas, TX55 kajian
Kajian lain di League City
- Kanser Paru-paru Bukan Sel Kecil15 kajian
- Kanser Metastatik7 kajian
- Kolitis Ulseratif6 kajian
- Kanser Paru-paru6 kajian
- Kanser Kolorektal6 kajian
- Kanser (semua jenis)5 kajian
- Kanser Ovari5 kajian
- Strok5 kajian
- Kanser Pundi Kencing4 kajian
- Karsinoma Sel Skuamosa Kepala dan Leher4 kajian
- Kanser Prostat4 kajian
- Keadaan Pasca-COVID (Long COVID)3 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.